Supernus Pharmaceuticals
SUPN
#4517
Rank
A$2.65 B
Marketcap
$48.19
Share price
0.91%
Change (1 day)
10.32%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.53 B

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.53 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.52 B-56.42%
2022-12-31A$1.19 B-0.12%
2021-12-31A$1.20 B21.9%
2020-12-31A$0.98 B22.62%
2019-12-31A$0.80 B7.9%
2018-12-31A$0.74 B270.34%
2017-12-31A$0.20 B23.03%
2016-12-31A$0.16 B18.32%
2015-12-31A$0.13 B17.89%
2014-12-31A$0.11 B34.8%
2013-12-31A$86.92 M147.46%
2012-12-31A$35.12 M-18.67%
2011-12-31A$43.19 M-52.12%
2010-12-31A$90.2 M-6.25%
2009-12-31A$96.21 M-20.78%
2008-12-31A$0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.53 B 186.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$87.35 B 16,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$116.35 B 21,546.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.18 B 9,235.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$164.31 B 30,468.54%๐Ÿ‡บ๐Ÿ‡ธ USA